Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myriad Genetics (MYGN) Change in Intangibles (2024 - 2025)

Historic Change in Intangibles for Myriad Genetics (MYGN) over the last 2 years, with Q3 2025 value amounting to $3.4 million.

  • Myriad Genetics' Change in Intangibles rose 2142.86% to $3.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.3 million, marking a year-over-year increase of 5833.33%. This contributed to the annual value of $300000.0 for FY2010, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Myriad Genetics' Change in Intangibles is $3.4 million, which was up 2142.86% from $4.1 million recorded in Q2 2025.
  • Over the past 5 years, Myriad Genetics' Change in Intangibles peaked at $4.1 million during Q2 2025, and registered a low of $1.9 million during Q1 2024.